The interval to spontaneous delivery following discontinuation of maintenance tocolysis

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 19, Issue 6, 2006, Pages 331-335

  Jones, J ^a   Morrison, John ^b   Istwan, Niki ^c   Rhea, Debbie ^c   Collins, Ann ^c   Stanziano, Gary ^c  

^a ABBOTT NORTHWESTERN HOSPITAL   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c Matria Healthcare Inc   (United States)

Author keywords

Maintenance tocolysis; Pregnancy outcome; Prematurity prevention

Indexed keywords

TERBUTALINE;

ADULT; ARTICLE; FEMALE; FETUS; FISHER EXACT TEST; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; KRUSKAL WALLIS TEST; LABOR INDUCTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; TOCOLYSIS; TWIN PREGNANCY; UTERINE CERVIX DILATATION; VAGINAL DELIVERY;

ADULT; DELIVERY, OBSTETRIC; FEMALE; GEORGIA; GESTATIONAL AGE; HUMANS; INJECTIONS, SUBCUTANEOUS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, MULTIPLE; REGISTRIES; TERBUTALINE; TIME FACTORS; TOCOLYSIS; TOCOLYTIC AGENTS; TWINS;

EID: 33745726383     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050500440853     Document Type: Article

References (21)

1. Sanchez-Ramos L, Kaunitz AM, Gaudier FL, Delke I. Efficacy of maintenance therapy after acute tocolysis: A meta-analysis. Am J Obstet Gynecol 1999;181:484-490.
2. Rust OA, Bofill JA, Arriola RM, Andrew ME, Morrison JC. The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol 1996;175:828-842.
3. Berg G, Anderson RGG, Ryden G. Beta-adrenergic receptors in human myometrium during pregnancy: Changes in the number of the receptors after beta-mimetic treatment. Am J Obstet Gynecol 1985;85:313-317.
4. Lam F, Bergauer NK, Jacques D, Coleman SK, Stanziano GJ. Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for the treatment of recurrent preterm labor in twin gestations. J Perinatol 2001;21:444-450.
5. Lam F, Istwan NB, Jacques D, Coleman SK, Stanziano GJ. Managing perinatal outcomes: The clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm labor. Manag Care 2003;12:39-46.
6. Fleming A, Bonebrake R, Istwan N, Rhea D, Coleman SK, Stanziano GJ. Pregnancy and economic outcomes in patients treated for recurrent preterm labor. J Perinatol 2004;24:223-227.
7. Elliott JP, Istwan NB, Rhea D, Stanziano G. The occurrence of adverse events in women receiving continuous subcutaneous terbutaline therapy. Am J Obstet Gynecol 2004;191:1277-1282.
8. Seubert DE, Stetzer BP, Wolfe HM, Treadwell MC. Delivery of the marginally preterm infant: What are the minor morbidities? Am J Obstet Gynecol 1999;181:1087-1091.
9. Konte JM, Holbrook RH, Laros RK Jr, Creasy RK. Short-term neonatal morbidity associated with prematurity and the effect of a prematurity prevention program on expected incidence of morbidity. Am J Perinatol 1986;3:283-288.
10. Macones GA, Bader TJ, Asch DA. Optimising maternal-fetal outcomes in preterm labour: A decision analysis. Br J Obstet Gynecol 1998;105:541-550.
11. Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A. Tocolytics for preterm labor: A systematic review. Obstet Gynecol 1999;94:869-877.
12. Higby K, Suiter CR. A risk benefit assessment of therapies for premature labor. Drug Saf 1999;1:35-56.
13. Morrison JC, Chauhan SP. Current status of home uterine activity monitoring. Clin Perinatol 2003;30:757-801.
14. Wenstrom KD, Weiner CP, Merrill D, Niebyl J. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery. J Perinatol 1997;14:87-91.
15. Guinn DA, Goepfert AR, Owen J, Wenstrom KD, Hauth JC. Terbutaline pump maintenance therapy for prevention of preterm delivery: A double blind trial. Am J Obstet Gynecol 1998;179:874-878.
16. American College of Obstetricians and Gynecologists. Technical Bulletin No. 206. Preterm Labor. Washington: The College; 1995.
17. Jones JS, Istwan NB, Jacques D, Coleman SK, Stanziano GJ. Is 34 weeks an acceptable goal for a complicated singleton pregnancy? Manag Care 2002;11:42-47.
18. Elliott JP, Istwan NB, Jacques DL, Coleman SK, Stanziano GJ. Consequences of nonindicated preterm delivery in singleton gestations. J Reprod Med 2003;48:713-717.
19. Gladstone IM, Katz VL. The morbidity of the 34 to 35 week gestation: Should we reexamine the paradigm? Am J Perinatol 2004;21:9-13.
20. Ladden M. The impact of preterm birth on the family and society. Part 1: Psychologic sequelae of preterm birth. Pediatr Nursing 1990;16:515-518.
21. Elliott JP, Istwan N, Collins A, et al. Indicated and non-indicated preterm delivery in twin gestations: Impact on neonatal outcome and cost. J Perinatol 2005;25:4-7.